HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Germinal testicular tumors in childhood. Report of observations and literature review.

Abstract
1,124 case observations, published from 1955 to 1981, and 45 of our own cases of childhood testicular tumor are evaluated. The age distribution, histology (WHO classification), stage and prognosis are compared to 1,062 adult cases. Diagnostic procedures are itemized. Priorities in the therapeutic approach and the effectiveness of various methods, depending on stage and histology, and toxic side effects and other complications are documented. In children, 29% of childhood testicular tumors are non-germinal, as compared to 8% in adults. 49% are yolk sac tumors. The age distribution differs depending on histology. Metastases occur less frequently (9%) than in adults (61%). Dissemination is predominantly hematogenic. Prognosis is best in teratoma which is cured by orchiectomy. Yolk sac tumor limited to the testicle, in infants less than 2 years old, is sufficiently treated with orchiectomy alone. Older children require adjuvant chemotherapy. Overall, chemotherapy was indicated in 15% of the evaluated cases of childhood testicular malignoma.
AuthorsL Weissbach, J E Altwein, R Stiens
JournalEuropean urology (Eur Urol) Vol. 10 Issue 2 Pg. 73-85 ( 1984) ISSN: 0302-2838 [Print] Switzerland
PMID6368238 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Choriocarcinoma (therapy)
  • Combined Modality Therapy
  • Dysgerminoma (therapy)
  • Humans
  • Infant
  • Male
  • Mesonephroma (therapy)
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prognosis
  • Teratoma (therapy)
  • Testicular Neoplasms (epidemiology, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: